These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
126 related articles for article (PubMed ID: 78950)
41. Cell-mediated lympholysis of trinitrophenyl-modified autologous lymphocytes. Effector cell specificity to modified cell surface components controlled by H-2K and H-2D serological regions of the murine major histocompatibility complex. Shearer GM; Rehn TG; Garbarino CA J Exp Med; 1975 Jun; 141(6):1348-64. PubMed ID: 47900 [TBL] [Abstract][Full Text] [Related]
42. In vitro induction of tumor-specific immunity. VI: analysis of specificity of immune response by cellular competitive inhibition: limitations and advantages of the technique. Chism SE; Burton RC; Grail DL; Bell PM; Warner NL J Immunol Methods; 1977; 16(3):245-62. PubMed ID: 68981 [TBL] [Abstract][Full Text] [Related]
43. Analysis of the mechanism of allograft rejection and cell-mediated immunity. II. Divergent effect of CY pretreatment on the generation of cytotoxic activity in the draining lymph nodes and spleen. Nanishi F; Taniguchi K; Kubo C; Onoyama K; Omae T; Nomoto K J Clin Lab Immunol; 1983 Sep; 12(1):23-30. PubMed ID: 6631941 [TBL] [Abstract][Full Text] [Related]
44. A micro-version of the 51Cr release assay for cytotoxic lymphocytes. Schnagl HY; Boyle W J Immunol Methods; 1978; 24(1-2):79-88. PubMed ID: 722093 [TBL] [Abstract][Full Text] [Related]
45. Augmentation of cell-mediated cytotoxicity by short-term in vitro precultivation of effector cells. Steinmuller D; Santee LJ; Krco CJ Transplant Proc; 1979 Mar; 11(1):834-6. PubMed ID: 377716 [No Abstract] [Full Text] [Related]
46. Generation of cytotoxic lymphocytes to syngeneic tumor by using co-stimulator (Interleukin 2). Mills GB; Paetkau V J Immunol; 1980 Nov; 125(5):1897-903. PubMed ID: 6159395 [TBL] [Abstract][Full Text] [Related]
47. Cellular and humoral immunity after allogeneic transplantation in the rat. II. Comparison of a 51Cr release assay and modified microcytotoxicity assay for detection of cellular immunity and blocking serum factors. Biesecker JL; Fitch FW; Rowley DA; Scollard D; Stuart FP Transplantation; 1973 Nov; 16(5):421-31. PubMed ID: 4584952 [No Abstract] [Full Text] [Related]
48. In vitro cytotoxicity and in vivo tumor enhancement induced by mouse spleen cells autosensitized in vitro. Ilfeld D; Carnaud C; Cohen IR; Trainin N Int J Cancer; 1973 Jul; 12(1):213-22. PubMed ID: 4133584 [No Abstract] [Full Text] [Related]
49. Secondary cytotoxic cell response to lymphocytic choriomeningitis virus. I. Kinetics of induction in vitro and yields of effector cells. Dunlop MB; Blanden RV Immunology; 1976 Aug; 31(2):171-80. PubMed ID: 955675 [TBL] [Abstract][Full Text] [Related]
50. Mechanism of cell-mediated cytotoxicity at the single cell level. II. Evidence for first-order kinetics of T cell-mediated cytolysis and for heterogeneity of lytic rate. Grimm EA; Thoma JA; Bonavida B J Immunol; 1979 Dec; 123(6):2870-7. PubMed ID: 315433 [TBL] [Abstract][Full Text] [Related]
51. Suppression of in vitro maintenance and interferon-mediated augmentation of natural killer cell activity by adherent peritoneal cells from normal mice. Brunda MJ; Taramelli D; Holden HT; Varesio L J Immunol; 1983 Apr; 130(4):1974-9. PubMed ID: 6187831 [TBL] [Abstract][Full Text] [Related]
52. Studies on the physiological manifestations of cell-mediated cytotoxicity. I. Early metabilic changes in mouse plasmacytoma cells exposed in vitro to sensitized allogeneic splenocytes. Steinitz M; Weiss DW Cell Immunol; 1975 Feb; 15(2):403-18. PubMed ID: 122916 [No Abstract] [Full Text] [Related]
53. Isotope-release cytotoxicity assay with the use of indium-111: advantage over chromium-51 in long-term assays. Wiltrout RH; Frost P; Cummings GD J Natl Cancer Inst; 1978 Jul; 61(1):183-8. PubMed ID: 97392 [TBL] [Abstract][Full Text] [Related]
54. Immune responses to mouse neuroblastoma C1300. I. Preliminary observations on cell-mediated immune responses. Phillips ME; Cipuzak PM; Penta DD; Schachner M J Natl Cancer Inst; 1977 Oct; 59(4):1215-9. PubMed ID: 903996 [TBL] [Abstract][Full Text] [Related]
55. Contrasting effects of alloandtiserum and xenoantiserum on cell-mediated lysis of tumor cells. Sonis ST; Stelos P; Kopelman JD; Wilson RE Cell Immunol; 1975 Apr; 16(2):251-60. PubMed ID: 1078791 [No Abstract] [Full Text] [Related]
56. Analysis of the mechanism of allograft rejection and cell-mediated immunity. I. Accelerated rejection of tumour allografts without augmented cytotoxicity in the spleen cells. Nanishi F; Nomoto K; Taniguchi K; Kubo C Immunology; 1980 May; 40(1):67-76. PubMed ID: 7419243 [TBL] [Abstract][Full Text] [Related]
57. A rapid and sensitive fluorometric microassay for determining cell mediated cytotoxicity to adherent growing cell lines. Krüger-Krasagakes S; Garbe C; Kossman P; Orfanos CE J Immunol Methods; 1992 Nov; 156(1):1-8. PubMed ID: 1431156 [TBL] [Abstract][Full Text] [Related]
58. Effect of tumor cells on the generation of cytotoxic T lymphocytes in vitro. I. Accessory cell functions of mouse tumor cells in the generation of cytotoxic T lymphocytes in vitro: replacement of adherent phagocytic cells by tumor cells or 2-mercaptoethanol. Koren HS; Hodes RJ Eur J Immunol; 1977 Jun; 7(6):394-400. PubMed ID: 302208 [TBL] [Abstract][Full Text] [Related]
59. Evaluation of tetrazolium-based semiautomatic colorimetric assay for measurement of human antitumor cytotoxicity. Heo DS; Park JG; Hata K; Day R; Herberman RB; Whiteside TL Cancer Res; 1990 Jun; 50(12):3681-90. PubMed ID: 2340518 [TBL] [Abstract][Full Text] [Related]
60. Generation of cytotoxic T lymphocytes in vitro. I. Response of normal and immune mouse spleen cells in mixed leukocyte cultures. Cerottini JC; Engers HD; Macdonald HR; Brunner T J Exp Med; 1974 Sep; 140(3):703-17. PubMed ID: 4278108 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]